Characteristics of T2D Patients Grouped by Glycemic Control (HbA1c < 7.0 mg/dL; HbA1c ≥ 7.0 mg/dL)
| . | HbA1c < 7.0 (n = 8) . | HbA1c ≥ 7.0 (n = 8) . |
|---|---|---|
| Age, y | 51.5 ± 3.1 | 59.4 ± 2.1 |
| Body mass, kg | 98.7 ± 5.5 | 111.7 ± 7.2 |
| BMI, kg/m2 | 32.8 ± 1.7 | 37.2 ± 2.1 |
| Sex, M/F | 5/3 | 6/2 |
| Race, C/AA | 3/5 | 6/2 |
| Duration of T2D, ya | 4.1 ± 0.9 | 8.8 ± 1.7 |
| Age of T2D onset, y | 47.4 ± 3.2 | 50.6 ± 2.9 |
| Stage* | 2.3 ± 0.2 | 3.3 ± 0.2 |
| Fasting glucose, mg/dLa | 113 ± 6 | 156 ± 15 |
| Fasting insulin, µIU/mLa | 15.8 ± 2.0 | 28.2 ± 7.8 |
| HOMA-IR | 4.4 ± 0.7 | 10.1 ± 2.9 |
| HOMA-β | 125.3 ± 21.1 | 189.0 ± 84.8 |
| Total cholesterol (mg/dL) | 171 ± 7 | 173 ± 11 |
| Triglycerides (mg/dL)a | 92 ± 8 | 164 ± 27 |
| HDL (mg/dL) | 46 ± 2 | 41 ± 3 |
| LDL (mg/dL) | 106 ± 6 | 99 ± 11 |
| SI (min−1 × μU−1 × mL−1)a | 2.1 ± 0.3 | 0.5 ± 0.2 |
| AIRg (μU × mL−1)a | 127.1 ± 46.0 | 5.0 ± 11.1 |
| HbA1c, %* | 6.2 ± 0.1 | 8.4 ± 0.4 |
| . | HbA1c < 7.0 (n = 8) . | HbA1c ≥ 7.0 (n = 8) . |
|---|---|---|
| Age, y | 51.5 ± 3.1 | 59.4 ± 2.1 |
| Body mass, kg | 98.7 ± 5.5 | 111.7 ± 7.2 |
| BMI, kg/m2 | 32.8 ± 1.7 | 37.2 ± 2.1 |
| Sex, M/F | 5/3 | 6/2 |
| Race, C/AA | 3/5 | 6/2 |
| Duration of T2D, ya | 4.1 ± 0.9 | 8.8 ± 1.7 |
| Age of T2D onset, y | 47.4 ± 3.2 | 50.6 ± 2.9 |
| Stage* | 2.3 ± 0.2 | 3.3 ± 0.2 |
| Fasting glucose, mg/dLa | 113 ± 6 | 156 ± 15 |
| Fasting insulin, µIU/mLa | 15.8 ± 2.0 | 28.2 ± 7.8 |
| HOMA-IR | 4.4 ± 0.7 | 10.1 ± 2.9 |
| HOMA-β | 125.3 ± 21.1 | 189.0 ± 84.8 |
| Total cholesterol (mg/dL) | 171 ± 7 | 173 ± 11 |
| Triglycerides (mg/dL)a | 92 ± 8 | 164 ± 27 |
| HDL (mg/dL) | 46 ± 2 | 41 ± 3 |
| LDL (mg/dL) | 106 ± 6 | 99 ± 11 |
| SI (min−1 × μU−1 × mL−1)a | 2.1 ± 0.3 | 0.5 ± 0.2 |
| AIRg (μU × mL−1)a | 127.1 ± 46.0 | 5.0 ± 11.1 |
| HbA1c, %* | 6.2 ± 0.1 | 8.4 ± 0.4 |
Abbreviations: AA, African American; C, Caucasian; F, female; HDL, high-density lipoprotein; LDL, low-density lipoprotein; M, male.
P ≤ 0.05.
Characteristics of T2D Patients Grouped by Glycemic Control (HbA1c < 7.0 mg/dL; HbA1c ≥ 7.0 mg/dL)
| . | HbA1c < 7.0 (n = 8) . | HbA1c ≥ 7.0 (n = 8) . |
|---|---|---|
| Age, y | 51.5 ± 3.1 | 59.4 ± 2.1 |
| Body mass, kg | 98.7 ± 5.5 | 111.7 ± 7.2 |
| BMI, kg/m2 | 32.8 ± 1.7 | 37.2 ± 2.1 |
| Sex, M/F | 5/3 | 6/2 |
| Race, C/AA | 3/5 | 6/2 |
| Duration of T2D, ya | 4.1 ± 0.9 | 8.8 ± 1.7 |
| Age of T2D onset, y | 47.4 ± 3.2 | 50.6 ± 2.9 |
| Stage* | 2.3 ± 0.2 | 3.3 ± 0.2 |
| Fasting glucose, mg/dLa | 113 ± 6 | 156 ± 15 |
| Fasting insulin, µIU/mLa | 15.8 ± 2.0 | 28.2 ± 7.8 |
| HOMA-IR | 4.4 ± 0.7 | 10.1 ± 2.9 |
| HOMA-β | 125.3 ± 21.1 | 189.0 ± 84.8 |
| Total cholesterol (mg/dL) | 171 ± 7 | 173 ± 11 |
| Triglycerides (mg/dL)a | 92 ± 8 | 164 ± 27 |
| HDL (mg/dL) | 46 ± 2 | 41 ± 3 |
| LDL (mg/dL) | 106 ± 6 | 99 ± 11 |
| SI (min−1 × μU−1 × mL−1)a | 2.1 ± 0.3 | 0.5 ± 0.2 |
| AIRg (μU × mL−1)a | 127.1 ± 46.0 | 5.0 ± 11.1 |
| HbA1c, %* | 6.2 ± 0.1 | 8.4 ± 0.4 |
| . | HbA1c < 7.0 (n = 8) . | HbA1c ≥ 7.0 (n = 8) . |
|---|---|---|
| Age, y | 51.5 ± 3.1 | 59.4 ± 2.1 |
| Body mass, kg | 98.7 ± 5.5 | 111.7 ± 7.2 |
| BMI, kg/m2 | 32.8 ± 1.7 | 37.2 ± 2.1 |
| Sex, M/F | 5/3 | 6/2 |
| Race, C/AA | 3/5 | 6/2 |
| Duration of T2D, ya | 4.1 ± 0.9 | 8.8 ± 1.7 |
| Age of T2D onset, y | 47.4 ± 3.2 | 50.6 ± 2.9 |
| Stage* | 2.3 ± 0.2 | 3.3 ± 0.2 |
| Fasting glucose, mg/dLa | 113 ± 6 | 156 ± 15 |
| Fasting insulin, µIU/mLa | 15.8 ± 2.0 | 28.2 ± 7.8 |
| HOMA-IR | 4.4 ± 0.7 | 10.1 ± 2.9 |
| HOMA-β | 125.3 ± 21.1 | 189.0 ± 84.8 |
| Total cholesterol (mg/dL) | 171 ± 7 | 173 ± 11 |
| Triglycerides (mg/dL)a | 92 ± 8 | 164 ± 27 |
| HDL (mg/dL) | 46 ± 2 | 41 ± 3 |
| LDL (mg/dL) | 106 ± 6 | 99 ± 11 |
| SI (min−1 × μU−1 × mL−1)a | 2.1 ± 0.3 | 0.5 ± 0.2 |
| AIRg (μU × mL−1)a | 127.1 ± 46.0 | 5.0 ± 11.1 |
| HbA1c, %* | 6.2 ± 0.1 | 8.4 ± 0.4 |
Abbreviations: AA, African American; C, Caucasian; F, female; HDL, high-density lipoprotein; LDL, low-density lipoprotein; M, male.
P ≤ 0.05.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
